17 completed, 12 unknown, 6 recruiting, 3 terminated. 42 Phase 1, 22 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 42 | Completed 17, Unknown 12, Recruiting 6, Terminated 3, Withdrawn 3, Not yet recruiting 1 |
| Phase 2 | 22 | Completed 9, Unknown 9, Recruiting 3, Not yet recruiting 1 |
Follow Control Group: new trials by email Literature Review of Control Group trials Research Report on Control Group
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Two Different Therapeutic Interventions Applied During Blood Sampling in Children experimental group, experiment group, Control Group - Blood Sampling, Child, Only | Phase 1 | Recruiting | Igdir University | 105 | 2026-08-01 | 2026-09-09 |
| hUC-MSC-Exosomes for T2DM - Safety & Efficacy exosomes treatment group, control group - Type 2 Diabetes Mellitus (T2DM) | Phase 1 / Phase 2 | Recruiting | Peking University First Hospital | 66 | 2026-06-05 | 2026-07-09 |
| A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) Treatment VUM02 Injection (UC-MSCs)+BAT, The control group with Best Available Therapy (BAT) - Steroid-refractory Acute Graft-versus-host Disease | Phase 1 / Phase 2 | Not yet recruiting | Wuhan Optics Valley Vcanbiopharma Co., Ltd. | 149 | 2025-01-01 | 2024-11-06 |
| UC-MSC Transplantation for Left Ventricular Dysfunction After AMI UC-MSC, Control Group - Left Ventricular Dysfunction, Acute Myocardial Infarction | Phase 1 | Withdrawn | Shanghai Life Science & Technology | 2024-12-01 | 2026-05-11 | |
| Study on Hibernation-like Therapy Based on Mechanical Thrombectomy chlorpromazine and promethazine, Placebo group, endovascular thrombectomy - Acute Ischemic Stroke | Phase 1 | Recruiting | Capital Medical University | 32 | 2024-11-09 | 2024-12-20 |
| Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding BT-114143 Injection at low dose, BT-114143 Injection at Medium-dose, BT-114143 Injection at High-dose - Abnormal Uterine Bleeding | Phase 1 | Recruiting | ScinnoHub Pharmaceutical Co., Ltd. | 39 | 2024-10-30 | 2025-12-15 |
| Flumazenil Antagonism of Remimazolam in Kidney Transplant Patients Flumazenil Injection（F1 group）, Flumazenil Injection（F2 group）, Saline（C group） - Flumazenil to Antagonize Remimazolam, Remimazolam | Phase 1 | Unknown | Qianfoshan Hospital | 60 | 2024-07-01 | 2024-08-01 |
| Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study. Insulin group, Botulinum toxin group, Triamcinolone acetonide group - Keloid | Phase 1 / Phase 2 | Unknown | Assiut University | 45 | 2024-05-01 | 2024-01-30 |
| Platelet Rich Plasma Combined With Human Umbilical Cord Mesenchymal Stem Cells for Stage 3 and 4 Stress Injury Platelet-rich plasma (PRP) combined with human umbilical cord mesenchymal stem cells (huMSCs), Control group - Pressure Injuries - Stage 3, Pressure Injuries - Stage 4 | Phase 1 / Phase 2 | Unknown | Liaocheng People's Hospital | 40 | 2024-02-29 | 2024-03-12 |
| Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Allogeneic umbilical cord mesenchymal stem cells, Control group - Multiple Sclerosis | Phase 1 / Phase 2 | Recruiting | Ever Supreme Bio Technology Co., Ltd. | 41 | 2023-09-08 | 2025-08-07 |
| Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes CELZ-201 Administration, Control Group - Type 1 Diabetes, Diabetes Mellitus, Type 1 | Phase 1 / Phase 2 | Recruiting | Creative Medical Technology Holdings Inc | 18 | 2023-04-07 | 2026-02-19 |
| Effects of the Adjunctive Use of Hyaluronic Acid-based Gel in the Surgical Periodontal Treatment of Periodontitis open flap debridement and Hyaluronic Acid-Based Gel application, open flap debridement - Periodontitis (Stage 3) | Phase 1 / Phase 2 | Completed | Ordu University | 18 | 2023-04-04 | 2025-02-24 |
| Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA) RSVt Vaccine, Control Group - Respiratory Syncytial Virus Infection | Phase 1 / Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 80 | 2023-02-06 | 2026-01-26 |
| Effects of Triiodothyronine (T3) in Ischemic Heart Failure Thyroid hormone T3, Control Group - Heart Failure | Phase 1 | Completed | Emory University | 14 | 2022-12-02 | 2026-08-04 |
| Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects SC1011, Placebo tablet - Idiopathic Pulmonary Fibrosis | Phase 1 | Completed | Guangzhou JOYO Pharma Co., Ltd | 45 | 2022-08-11 | 2023-11-18 |
| Effect of Dexmedetomidine on Prevention of Postoperative Nausea and Vomiting in Children Dexamethasone, Ondansetron, Dexmedetomidine - Postoperative Nausea and Vomiting, Post Operative Pain | Phase 1 | Completed | Tanta University | 4 | 2021-10-27 | 2022-04-05 |
| Polaprezinc Treatment for Enzalutamide- or Abiraterone-resistant CRPC Polaprezinc group, Control group - Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | Completed | Jiangnan University | 12 | 2021-01-06 | 2023-07-11 |
| Using Vedolizumab-800CW to Gain Insight Into Local Drug Distribution and Mucosal Target Cells in IBD Patients Fluorescence molecular imaging procedure using vedolizumab-800CW, Fluorescence molecular imaging procedure without prior administration of vedolizumab-800CW, Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration of unlabeled vedolizumab - Crohn Disease, Colitis, Ulcerative | Phase 1 | Completed | University Medical Center Groningen | 38 | 2020-11-04 | 2024-04-16 |
| The Evaluation of Postoperative Antibiotics in Non-Infected Mandible Fractures Antibiotic treatment (Unasyn or Cleocin), Antibiotic treatment (Augmentin or Cleocin), Control Group - Jaw Fractures, Infection | Phase 1 | Terminated | The University of Texas Health Science Center, Houston | 13 | 2020-10-01 | 2025-06-26 |
| The Effectiveness of High-dose Intravenous Vitamin c With Very Low Carbohydrate Diet for Terminal Colon Cancer Patients Ascorbic Acid, Control group - Colon Cancer Stage Iv | Phase 1 / Phase 2 | Unknown | National Taiwan University Hospital | 40 | 2020-01-01 | 2019-07-29 |
Showing 20 of 42. Sign in to see all of them.
Heart Failure (2) · Multiple Sclerosis (2) · Pain (2) · Periodontitis (2) · Amyotrophic Lateral Sclerosis (1) · Bronchiectasis (1) · Colitis, Ulcerative (1) · Colonic Neoplasms (1) · Crohn Disease (1) · Dental Caries (1) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Emergence Delirium (1) · Gingival Recession (1) · Hernia, Abdominal (1)
Capital Medical University (2) · Meir Medical Center (2) · University of Sao Paulo (2) · Ahmed A. H. Abdellatif (1) · American University of Beirut Medical Center (1) · Assiut University (1) · Benha University (1) · Corestemchemon, Inc. (1) · Creative Medical Technology Holdings Inc (1) · Emory University (1) · Ever Supreme Bio Technology Co., Ltd. (1) · Ferrer Internacional S.A. (1) · French Cardiology Society (1) · Guangzhou JOYO Pharma Co., Ltd (1) · Igdir University (1)
China (9) · United States (5) · Egypt (4) · India (3) · Brazil (2) · Israel (2) · Taiwan (2) · Turkey (Türkiye) (2) · Canada (1) · Denmark (1) · France (1) · Iran (1) · Italy (1) · Lebanon (1) · Malawi (1)
Abubaker M Elnashar, MD (1) · Ada C Gastaldi, PHD (1) · Ada C. Gastaldi, doctor (1) · Andrew Copp, Prof (1) · Arshed A. Quyyumi, MD (1) · Bojan Vrtovec, MD, PhD (1) · Cameron R. Smith, M.D., Ph.D. (1) · Chengxing Shen, Dr. (1) · Chin-Ying Chen, MD, MHSc (1) · Dr.Chandrika Dubey, MDS (1) · Ezequiel Palmanovich, MD (1) · Francesco Vendrame, MD (1)
PMID 10434461, PMID 11978924, PMID 1280928, PMID 15362760, PMID 19063954, PMID 19572819, PMID 20148633, PMID 21229331, PMID 23635074, PMID 25934946, PMID 26276254, PMID 28733314, PMID 28880460, PMID 30048006, PMID 31600109, PMID 33607926, PMID 34119741, PMID 34214585, PMID 35291004, PMID 35547633, PMID 37711926, PMID 37924749, PMID 38580386, PMID 9674466
R01HD074944 (1)